Abstract. Introduction: Long antibiotic courses, including intravenous (IV) and oral administrations,
are utilized in prosthetic joint infection (PJI) treatment. This
meta-analysis examines the non-inferiority of short courses (< 4 weeks)
of IV antibiotics compared to long courses in treating PJI. Critical review
of IV treatment is necessary due to the clinical, physical, and financial
burden associated with it and its continued prolonged use in the US without much evidence to support the practice.
Methods: Following the Preferred Reporting Items for Systematic Reviews and
Meta-Analyses (PRISMA), databases were searched using predefined medical
subject headings (MeSH).
Results: The nine included studies reported 521 total hip arthroplasties (THAs) and
530 total knee arthroplasties (TKAs). There was no significant difference in
the overall success rate in short- vs. long-duration IV antibiotics for PJI treatment: odds ratio (OR) of 1.65, 95 % confidence interval (CI) of 0.78–3.46, and p=0.18. However, due to the
moderate to high heterogeneity (I2=68 %, p < 0.01) amongst
studies, an adjusted success rate was calculated after the exclusion of two
studies. This showed a statistically significant difference between both
groups (OR of 2.45, 95 % CI of 1.21–4.96, p < 0.001) favoring a short
course of antibiotics and reflecting a more homogenous population (I2=51 %, p=0.06).
Conclusion: This study highlights the limited data available for evaluating IV antibiotic
duration in the setting of PJI. We found that a shorter duration of IV
antibiotics was non-inferior to a longer duration, with an improved OR of
2.45 for treatment success, likely shortening inpatient stay as well as lessening side
effects and antimicrobial resistance with a lower cost to patients and
overall healthcare.